Advaxis Announces GOG-0265 12-month Overall Survival Rate of 37.5% in Stage 2
Oct 24, 2016 12:01 pm UTC| Business
Data in 50 patients with recurrent metastatic carcinoma of the cervix demonstrates a 52% increase in 12-month overall survival rate PRINCETON, N.J., Oct. 24, 2016 -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage...
Nearly 8 in 10 Businesses Used Financing to Acquire Equipment in 2015, New Study Reveals
Oct 24, 2016 12:01 pm UTC| Business
WASHINGTON, Oct. 24, 2016 -- Seventy-eight percent of respondents in a survey of businesses used at least one form of financing when acquiring equipment in FY 2015, according to the U.S. Equipment Finance Market Study:...
Sun BioPharma, Inc. to Present at the Innovation Biotech Showcase on October 26th
Oct 24, 2016 12:01 pm UTC| Business
MINNEAPOLIS, Oct. 24, 2016 -- Sun BioPharma, Inc. (OTCQB:SNBP), a biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic diseases, today announced that the Company...
FRONTEO Expands Global eDisclosure Services to Meet Growth in EMEA
Oct 24, 2016 12:01 pm UTC| Business
NEW YORK, Oct. 24, 2016 -- FRONTEO USA, Inc. (“FRONTEO USA”), a wholly-owned direct subsidiary of FRONTEO, Inc. (“FRONTEO”) (formerly known as UBIC, Inc.) (NASDAQ:FTEO) (TSE:2158), a leading provider of global...
FRONTEO Expands Global eDisclosure Services to Meet Growth in EMEA
Oct 24, 2016 12:01 pm UTC| Business
NEW YORK, Oct. 24, 2016 -- FRONTEO USA, Inc. (“FRONTEO USA”), a wholly-owned direct subsidiary of FRONTEO, Inc. (“FRONTEO”) (formerly known as UBIC, Inc.) (NASDAQ:FTEO) (TSE:2158), a leading provider of global...
Oct 24, 2016 12:00 pm UTC| Business
BOSTON, Oct. 24, 2016 -- Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, announced...
Oct 24, 2016 12:00 pm UTC| Business
Second Quarter Net Income Increased 9%Second Quarter Sales Increased 7% POMPANO BEACH, Fla., Oct. 24, 2016 -- PetMed Express, Inc. (NASDAQ:PETS) today announced its financial results for the quarter ended...